Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ranbaxy Establishes Presence In Yemen

This article was originally published in PharmAsia News

Executive Summary

Ranbaxy Laboratories of India has entered into a partnership with Natco to establish the Indian drug maker's presence in the Middle Eastern country. At a recent event, Ranbaxy introduced its products to Yemeni physicians interested in anti-infectives, gastro-Intestinal, cholesterol-lowering and anti-allergic drug treatments. Ranbaxy thus became India's first company with a major presence in West Asia, adding to its ties with several other countries in the area. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts